C-Reactive Protein (CRP) Testing Market Overview 2025–2033 The global C-Reactive Protein (CRP) Testing Market is poised for steady growth, driven by the increasing prevalence of chronic inflammatory diseases, infections, and cardiovascular conditions. Valued at USD 3.1 billion in 2025, the market is projected to reach USD 5.8 billion by 2033, reflecting...

Handheld fractional exhaled nitric oxide (FeNO) monitors — the portable, electrochemical sensor-based devices measuring airway inflammation at ppb levels in 10 seconds at the point-of-care — represent the fastest-growing segment in the respiratory diagnostics market, with the Feno Monitor Market reflecting handheld FeNO as the asthma phenotype-guided therapy commercial driver....

C-Reactive Protein Testing Market Size, Share, Industry Analysis & Forecast 2033 Introduction C-Reactive Protein Testing Market is experiencing steady growth as healthcare providers increasingly rely on diagnostic biomarkers to detect inflammation, infections, and cardiovascular conditions. C-reactive protein (CRP) is a substance produced by the liver in response to inflammation, and...

AI-powered digital morphology in hematology analyzers — the artificial intelligence-enhanced automated cell classification, abnormal population detection, and predictive biomarker analysis representing the fastest-advancing technology in the global hematology diagnostics landscape — creates the most commercially dynamic innovation pressure, with the Hematology Analyzers And Reagent...

Point-of-care hepatitis B diagnostics — the deployment of rapid immunochromatographic HBsAg tests, dried blood spot (DBS) HBV DNA viral load testing, and portable serology platforms enabling HBV diagnosis and treatment eligibility assessment outside of centralized reference laboratory settings — creating the diagnostic access expansion essential for bridging the gap between HBV...

Point-of-care hepatitis B diagnostics — the deployment of rapid immunochromatographic HBsAg tests, dried blood spot (DBS) HBV DNA viral load testing, and portable serology platforms enabling HBV diagnosis and treatment eligibility assessment outside of centralized reference laboratory settings — creating the diagnostic access expansion essential for bridging the gap between HBV...

In Vitro Diagnostics Market: Industry Growth, Trends and Forecast 2033 Introduction The In Vitro Diagnostics Market is experiencing steady growth as healthcare systems worldwide emphasize early disease detection and accurate diagnostic testing. In vitro diagnostics (IVD) involve tests performed on biological samples such as blood, urine, or tissue outside the human body to detect...

According to the latest report published by Data Bridge Market Research, the Over the Counter (OTC)/Direct to Consumer (DTC) Infectious Disease Diagnostics Market The global Over the Counter (OTC)/Direct to Consumer (DTC) Infectious Disease Diagnostics market size was valued at USD 1.64 billion in 2025 and is expected to reach USD 4.12 billion by 2033, at a CAGR of 12.23% during the...

Market Overview The Portable Urine Analyzers Market is experiencing significant growth as healthcare systems increasingly adopt point-of-care testing solutions for rapid, accurate, and convenient diagnostic capabilities. Portable urine analyzers are compact devices that enable quick assessment of various urine parameters, including glucose, protein, pH, and specific gravity,...